Physician profile
John R Scott
NPI 1336204544
$13,272.18
in general payments reported to CMS, 2019-2025
17 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.79 · 2020: $6,440 · 2021: $730 · 2022: $683 · 2023: $4,789 · 2024: $416 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,241 · Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,241.17 |
| Food and Beverage | $1,164.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,394.50 | 2020-2025 | Da Vinci Surgical System |
| Steris Corporation | $4,260.42 | 2023 | |
| Stryker Corporation | $196.06 | 2020-2023 | 1688 |
| Intra-Sana Laboratories | $107.84 | 2022-2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Becton, Dickinson and Company | $94.34 | 2024 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $34.45 | 2021-2025 | Bridion |
| Olympus America INC. | $33.79 | 2022-2023 | Visera Video System Center Otv-S7v Camera Head |
| Tela Bio, INC. | $20.39 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innocoll Pharmaceuticals Limited | $19.52 | 2022 | |
| Medical Device Business Services, INC. | $19.25 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $16.84 | 2023 | Caldolor |
| Hologic Sales and Service, LLC | $16.63 | 2023 | Coolseal Generator |
| Baxter Healthcare | $16.38 | 2022 | |
| Smith+Nephew, INC. | $15.26 | 2022 | |
| Mallinckrodt Enterprises LLC | $13.79 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.72 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.